Agile therapeutics announces 1-for-40 reverse stock split

Princeton, n.j., april 26, 2022 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx) (“agile”), a women's healthcare company, today announced that the board approved a 1-for-40 reverse stock split, to be effective 5:00 p.m. on tuesday, april 26, 2022. the company's common stock will open for trading on the nasdaq market on wednesday, april 27, 2022 on a split-adjusted basis under the current trading symbol "agrx." the reverse stock split was approved by agile's stockholders on april 21, 2022 and is intended to increase the per share trading price of the company's common stock to enable the company to satisfy the minimum bid price requirement for continued listing on the nasdaq capital market.
AGRX Ratings Summary
AGRX Quant Ranking